Rentokil
226 hedge funds and large institutions have $1.71B invested in Rentokil in 2024 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 65 increasing their positions, 93 reducing their positions, and 33 closing their positions.
33% more call options, than puts
Call options by funds: $7.95M | Put options by funds: $5.98M
30% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 33
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
9% more capital invested
Capital invested by funds: $1.57B → $1.71B (+$134M)
3% more funds holding
Funds holding: 220 → 226 (+6)
0.15% more ownership
Funds ownership: 2.52% → 2.67% (+0.15%)
30% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 93
Top Buyers
| 1 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
+$51.2M |
| 2 |
GCM
Gates Capital Management
New York
|
+$27.5M |
| 3 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$24.3M |
| 4 |
Rockefeller Capital Management
New York
|
+$14.5M |
| 5 |
VC
Voss Capital
Houston,
Texas
|
+$13.7M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$11.4M |
| 2 |
MIS
Morningstar Investment Services
Chicago,
Illinois
|
-$10.7M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$10.6M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$7.98M |
| 5 |
Barclays
London,
United Kingdom
|
-$7.55M |
RTO Hedge Fund Activity: Q4 2024 in Review
226 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Rentokil (RTO) for Q4 2024, worth a combined $1.71B — up 8.5% from $1.57B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new RTO positions and 33 closed out — a net gain of 10 holders — while 65 added to existing stakes and 93 trimmed.
The largest buyer was River Road Asset Management, adding an estimated $51.2M. The largest seller was Goldman Sachs, cutting an estimated $11.4M.
- 226 institutional investors held Rentokil (RTO) as of Q4 2024, up from 220 in Q3 2024.
- Funds reported $1.71B of Rentokil stock for Q4 2024, up 8.5% quarter-over-quarter.
- 43 funds opened new Rentokil positions in Q4 2024 and 33 closed out, a net change of +10 holders.
- The largest Rentokil buyer in Q4 2024 was River Road Asset Management, an estimated $51.2M added.
- The largest Rentokil seller in Q4 2024 was Goldman Sachs, an estimated $11.4M sold.
Based on aggregated 13F filings for Q4 2024.